IL17A and breast carcinoma: Previous research has shown that mutations in the IL-17F and IL-17A genes lead to inflammatory disorders such as inflammatory bowel disease [21], asthma [22], rheumatoid arthritis [23], ovarian carcinoma [24], and colon and breast cancer [25,26].